Literature DB >> 30345184

A Survival Case of Super-refractory Status Epilepticus due to Glutamic Acid Decarboxylase Antibodies-associated Limbic Encephalitis.

Baoqiong Liu1, Yan Zhou2, Lingbin Meng1, Holly Skinner3.   

Abstract

Limbic encephalitis (LE) is a neurological syndrome that mainly affects mesial temporal lobes. It may present in association with cancer or infection. Limbic encephalitis associated with glutamic acid decarboxylase antibodies (anti-GAD) is rare. Here, we report a case of anti-GAD limbic encephalitis to heighten the awareness of this rare cause of autoimmune encephalitis. Anti-GAD-associated epilepsy is often poorly responsive to seizure medications. Treatment is challenging. Early initiation of immunotherapy is important.

Entities:  

Keywords:  glutamic acid decarboxylase antibodies; immunotherapy; limbic encephalitis; refractory seizures

Year:  2018        PMID: 30345184      PMCID: PMC6181246          DOI: 10.7759/cureus.3125

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Anti-GAD antibodies, a rare cause of limbic encephalitis: a case report.

Authors:  Yannick Van Ael; Rizvana Amir; Patrick Cras
Journal:  Acta Neurol Belg       Date:  2015-06-02       Impact factor: 2.396

2.  Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.

Authors:  N Hansen; G Widman; J-A Witt; J Wagner; A J Becker; C E Elger; C Helmstaedter
Journal:  Epilepsy Behav       Date:  2016-11-15       Impact factor: 2.937

Review 3.  Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.

Authors:  Ahmad Daif; Rimas V Lukas; Naoum P Issa; Adil Javed; Stephen VanHaerents; Anthony T Reder; James X Tao; Peter Warnke; Sandra Rose; Vernon L Towle; Shasha Wu
Journal:  Epilepsy Behav       Date:  2018-02-09       Impact factor: 2.937

4.  GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.

Authors:  A Boronat; L Sabater; A Saiz; J Dalmau; F Graus
Journal:  Neurology       Date:  2011-03-01       Impact factor: 9.910

5.  Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.

Authors:  Helena Ariño; Romana Höftberger; Nuria Gresa-Arribas; Eugenia Martínez-Hernández; Thaís Armangue; Michael C Kruer; Javier Arpa; Julio Domingo; Bojan Rojc; Luis Bataller; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

6.  Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies.

Authors:  Sabrina Matà; Gian Carlo Muscas; Ilaria Naldi; Eleonora Rosati; Sergio Paladini; Barbara Cruciatti; Francesca Bisulli; Marco Paganini; Gustavo Mazzi; Sandro Sorbi; Paolo Tinuper
Journal:  J Neuroimmunol       Date:  2008-06-30       Impact factor: 3.478

7.  Distinct white matter integrity in glutamic acid decarboxylase and voltage-gated potassium channel-complex antibody-associated limbic encephalitis.

Authors:  Jan Wagner; Jan-Christoph Schoene-Bake; Juri-Alexander Witt; Christoph Helmstaedter; Michael P Malter; Winfried Stoecker; Christian Probst; Bernd Weber; Christian E Elger
Journal:  Epilepsia       Date:  2016-01-08       Impact factor: 5.864

8.  Autoimmune Limbic Encephalitis With GAD Antibodies.

Authors:  Pasquale F Finelli
Journal:  Neurohospitalist       Date:  2011-10

Review 9.  Anti-glutamic acid decarboxylase antibody positive neurological syndromes.

Authors:  Hassaan Tohid
Journal:  Neurosciences (Riyadh)       Date:  2016-07       Impact factor: 0.906

10.  GAD65 Positive Autoimmune Limbic Encephalitis: A Case Report and Review of Literature.

Authors:  Abhishek Sharma; Divyanshu Dubey; Anshudha Sawhney; Kalyana Janga
Journal:  J Clin Med Res       Date:  2012-11-11
  10 in total
  2 in total

Review 1.  Neuropsychiatric Disorders Due to Limbic Encephalitis: Immunologic Aspect.

Authors:  Yu-Chia Kao; Ming-I Lin; Wen-Chin Weng; Wang-Tso Lee
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

2.  Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?

Authors:  Tao-Ran Li; Yu-Di Zhang; Qun Wang; Xiao-Qiu Shao; Zhi-Mei Li; Rui-Juan Lv
Journal:  BMC Neurosci       Date:  2020-03-30       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.